Wildfires such as those that hit Canada last month are a growing worry, writes Marc-André Parisien, but risk-assessment models can limit future damage.
Nature 534 297 doi: 10.1038/534297a
Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that failed in initial trials.
Nature 534 314 doi: 10.1038/534314a
Firms chase a new breed of advanced veterinary care, from antibodies to cell therapies.
Nature 534 303 doi: 10.1038/534303a